Characteristics and anticancer interventions (ACIs) in African American (AA) and Caucasian (CAU) patients (pts) treated with sipuleucel-T (sip-T): Real-world experience from the PROCEED registry.

Authors

Andrew Armstrong

Andrew J. Armstrong

Duke University Medical Center, Duke Cancer Institute Divisions of Medical Oncology and Urology, Duke University, Durham, NC

Andrew J. Armstrong , Celestia S. Higano , Matthew R. Cooperberg , Chiledum Ahaghotu , Ronald F. Tutrone , Laurence H. Belkoff , Carl A. Olsson , Sanjay Goel , Robert Claude Tyler , Nancy N. Chang , Jennifer Susan LIll , A. Oliver Sartor

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary (Prostate) Cancer

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT01306890

Citation

J Clin Oncol 34, 2016 (suppl; abstr 5025)

DOI

10.1200/JCO.2016.34.15_suppl.5025

Abstract #

5025

Poster Bd #

282

Abstract Disclosures